Evaluation of the Efficacy of Diagnostic Support Algorithms in Chest X-rays- LuAna Trial
Launched by HOSPITAL ISRAELITA ALBERT EINSTEIN · Nov 11, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The LuAna Trial is studying how well artificial intelligence (AI) can help doctors detect issues in chest X-rays for adults who have breathing problems. The main goal is to see if using AI alongside doctors increases the chances of finding important health issues, like lung injuries or fluid in the lungs, compared to doctors working alone without AI support. This trial will take place in various hospitals and clinics, ensuring that the AI tool is tested on a wide range of patients from different backgrounds.
To be eligible for this trial, participants must be over 18 years old and have chest X-rays taken while experiencing respiratory symptoms. The X-rays should show at least one clear frontal view of the chest. However, individuals who had their X-rays done for specific reasons like trauma or cancer screening will not be included. If you choose to participate, you can expect that the trial will focus on improving the way chest X-rays are interpreted, which could lead to better care and faster diagnoses for patients in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Non-reported chest X-rays (XRts) of individuals aged over 18 years.
- • Individuals images with respiratory complaints.
- • Chest X-rays taken during the presence of these respiratory symptoms or while being followed up for respiratory disease.
- • Chest X-rays taken on any X-ray machine.
- • Chest X-rays that include at least one frontal view of the chest.
- Exclusion Criteria:
- • Those whose chest X-ray was performed due to a history of trauma, pre-operative risk assessment, lung cancer screening, or exclusively for verifying the correct positioning of a peripheral intravenous catheter (PICC).
- • Chest X-rays with technical quality below the minimum required for proper interpretation and diagnosis.
- • Cases without at least one frontal view.
- • X-rays printed on regular paper.
About Hospital Israelita Albert Einstein
Hospital Israelita Albert Einstein is a leading healthcare institution in Brazil, renowned for its commitment to excellence in patient care, education, and research. As a prominent clinical trial sponsor, the hospital emphasizes innovation and scientific advancement, facilitating cutting-edge studies across various medical disciplines. With a state-of-the-art infrastructure and a dedicated team of professionals, Hospital Israelita Albert Einstein fosters collaboration with global research networks to enhance clinical outcomes and contribute to the advancement of medical knowledge. The institution is dedicated to adhering to the highest ethical standards and regulatory compliance, ensuring the safety and well-being of trial participants.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Joselisa Paiva, PhD
Principal Investigator
Hospital Israelita Albert Einstein
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported